Navigation Links
Neogen Acquires Gen-Probe's BioKits Food Safety Business
Date:12/1/2009

LANSING, Mich., Dec. 1 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today that it has acquired the BioKits food safety business of San Diego, Calif.-based Gen-Probe Incorporated ( GPRO). The acquisition includes more than 50 test kits for food allergens, meat and fish speciation, and plant genetics.

Gen-Probe acquired the BioKits business through its acquisition of Tepnel Life Sciences plc in April 2009. Gen-Probe elected to divest the food safety business of United Kingdom-based Tepnel as it did not fit into its long-term strategic plans. Tepnel's food safety business is a freestanding operation employing approximately 25 people in Deeside, Wales. Tepnel was founded in 1992, and its food safety business is expected to record revenues of approximately $3 million (U.S.) this year. Terms of the acquisition were not disclosed.

"This acquisition provides a good opportunity for Neogen since the markets and products are both synergistic to our continued growth," said James Herbert, Neogen's CEO. "Gen-Probe has a number of food allergen diagnostic tests that are not currently offered by Neogen, and an attractive line of tests to determine meat speciation as a tool to prevent economic adulteration. The business also has a good market position in several European countries that will add to the market penetration of our Scotland-based Neogen Europe operations."

"Divesting Tepnel's BioKits food testing business will help Gen-Probe tighten our strategic focus on human molecular diagnostic opportunities," said Carl Hull, Gen-Probe's President and CEO. "We are pleased to see this business now under the direction of Neogen Corporation, a company we respect as being one of the world leaders in food safety. This will provide a continuation of service to our worldwide customers."

The Deeside, Wales facilities will operate as a unit of Neogen's wholly owned subsidiary, Neogen Europe Ltd., based in Ayr, Scotland. In addition to the product line of diagnostic test kits, the acquired food safety business provides specialized independent laboratory services to a number of companies.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's most recently filed Form 10-K.

SOURCE Neogen Corporation


'/>"/>
SOURCE Neogen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
2. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
3. U.S. Preventive Medicine Acquires Specialty Disease Management
4. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
5. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
6. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
7. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
8. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
9. Wound Management Technologies Acquires Resorbable Orthopedics
10. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
11. Kimberly-Clark Acquires Baylis Medical Companys Pain Management Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations ... Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
Breaking Medicine News(10 mins):